Skip to content
10-Q

Quarterly Report

Creative Medical Technology Holdings, Inc. CELZ

0001477932-25-003498

← back to feed
Filed
May 9, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 9, 2025 2.59M sh
Stockholders Equity Q1 2025 · Mar 31, 2025 $8.06M
Stockholders Equity Q1 2025 · Dec 31, 2024 $6.34M
Stockholders Equity Q1 2025 · Mar 31, 2024 $9.23M
Stockholders Equity Q1 2025 · Dec 31, 2023 $10.34M
Current Liabilities Q1 2025 · Mar 31, 2025 $286.39K
Current Liabilities Q1 2025 · Dec 31, 2024 $327.64K
Total Liabilities Q1 2025 · Mar 31, 2025 $286.39K
Total Liabilities Q1 2025 · Dec 31, 2024 $327.64K
Current Assets Q1 2025 · Mar 31, 2025 $7.84M
Current Assets Q1 2025 · Dec 31, 2024 $6.14M
Total Assets Q1 2025 · Mar 31, 2025 $8.35M
Total Assets Q1 2025 · Dec 31, 2024 $6.67M
Shares Diluted Q1 2025 · Mar 31, 2024 1.42M sh
Stock Repurchased Q1 2025 · Mar 31, 2024 $82.8K
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$896.86K
Eps Diluted Q1 2025 · Mar 31, 2024 $0.73
Sga Expense Q1 2025 · Mar 31, 2024 $671.48K
Rd Expense Q1 2025 · Mar 31, 2024 $422.39K
Net Income Q1 2025 · Mar 31, 2024 −$1.04M
Operating Income Q1 2025 · Mar 31, 2024 −$1.12M
Gross Profit Q1 2025 · Mar 31, 2024 $0
Cost Of Revenue Q1 2025 · Mar 31, 2024 $0
Revenue Q1 2025 · Mar 31, 2024 $0